Related Experiment Video
Updated: May 4, 2026
07:40
Gene Transfection toward Spheroid Cells on Micropatterned Culture Plates for Genetically-modified Cell Transplantation
Published on: July 31, 2015
8.0K
An injectable spheroid system with genetic modification for cell transplantation therapy
Satoshi Uchida1, Keiji Itaka1, Takahiro Nomoto2
1Division of Clinical Biotechnology, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Biomaterials
|January 7, 2014
Summary
This study introduces a novel method using 3D hepatocyte spheroids for enhanced cell transplantation therapy. Genetically modified spheroids show sustained transgene expression and preserved function, outperforming traditional cell suspensions.
Area of Science:
- Regenerative Medicine
- Biotechnology
- Cell Therapy
Background:
- Cell transplantation efficacy is often limited by poor survival and function of transplanted cells.
- Genetic modification of cells can enhance therapeutic outcomes but requires efficient delivery and engraftment methods.
Purpose of the Study:
- To develop a novel cell transplantation methodology using three-dimensional (3D) spheroids for enhanced therapeutic potential.
- To evaluate the efficacy of genetically modified hepatocyte spheroids compared to single-cell suspensions for therapeutic applications.
Main Methods:
- Primary hepatocytes were genetically modified using non-viral polyplex nanomicelles and formed into 100-μm spheroids on micropatterned plates.
- Spheroids were recovered as injectable suspensions by cooling thermosensitive polymer-coated plates.
- Subcutaneous transplantation of hepatocyte spheroids and single-cell suspensions was performed, followed by transgene expression analysis and functional assessment.
Main Results:
- Hepatocyte spheroids demonstrated sustained transgene expression (luciferase) in host tissue for over a month, unlike transient expression from single-cell suspensions.
- Transplanted spheroids preserved innate hepatocyte functions, including albumin expression.
- Intravital imaging revealed spheroid cells localized near blood vessels, suggesting a supportive microenvironment.
- Erythropoietin-expressing spheroids induced a significantly higher hematopoietic effect than cell suspensions.
Conclusions:
- The developed 3D spheroid transplantation system, combined with genetic modification, significantly enhances therapeutic potential compared to traditional cell suspensions.
- This methodology offers a promising strategy for improving cell therapy by preserving cell function and promoting engraftment.
- The system holds high potential for various therapeutic applications, including regenerative medicine and gene therapy.
